United States · FDA National Drug Code directory
BETHKIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-820_32442297-00c4-4800-b7c4-1e2e290f3162
- Product NDC
- 10122-820
- Form
- SOLUTION
- Composition / generic term
- tobramycin
- Labeler
- Chiesi USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130415
- Source listing expiry
- 20261231
Source-listed ingredients
- TOBRAMYCIN — 300 mg/4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE · 10122-820-04
- 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE · 10122-820-28
- 14 POUCH in 1 CARTON (10122-820-56) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE · 10122-820-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →